Persistent hiccups after acute COVID-19 successfully treated with chlorpromazine: a case report.

Persistent hiccups after acute COVID-19 successfully treated with chlorpromazine: a case report.

Publication date: Jun 19, 2024

Hiccups are among the rare complications of COVID-19 infections. There are several published reports of persistent hiccups presenting during the acute COVID-19 period. However, there are very few published reports of persistent hiccups occurring in the post-acute COVID-19 period. Consequently, most clinicians may not be aware of this rare presentation. This case highlights an atypical presentation of persistent hiccups that manifested during the post-acute COVID -19 period that clinicians need to be aware of. The caseadds to the ever increasing body of knowledge about symptoms and signs associated with Severe Acute Respiratory Syndrome Corona Virus type 2 (SARS CoV-2) infection. A 27 year old male black Zambian patient presented to the emergency department of our hospital with persistent hiccup, 35 days after the initial acute episode of COVID-19. This was associated with breathlessness. There were no other symptoms. He had no history of pulmonary, gastrointestinal, neurological disease or malignancy. He did not take any alcohol or smoke. He had never used any recreational drugs. He was employed as a monitoring and evaluation officer at one of the main COVID centres in the capital. On examination, the patient was anxious. Blood pressure was 141/82, pulse rate was 95 beats per minute, respiratory rate was 26 breaths per minute, temperature was 36. 8C and oxygen saturation was 97% on room air. Systemic examination was normal. Chest X-ray and abdominal ultrasonography were normal. A rapid COVID-19 antigen test, and COVID-19 Polymerase Chain Reaction (PCR) test that were done the following day were negative. All other haematological and biochemical tests, including D-dimer and C-reactive protein (CRP), were also normal. A diagnosis of post-acute COVID-19 associated hiccups was made. The patient responded well to treatment with chlorpromazine 25 mg 8 hourly. The hiccups disappeared completely after the fourth dose of chlorpromazine. This is one of the few published cases of COVID-19 associated persistent hiccups, occurring more than a month after the initial presentation. Most of the published cases report hiccups occurring in the acute COVID-19 period. Consequently, hiccups occurring in the post-acute COVID-19 period may not be attributable to COVID-19. This case has highlighted the need to consider post-acute COVID-19 in the differential diagnosis of persistent hiccup.

Concepts Keywords
27year Adult
Gastrointestinal Atypical
Pcr Case report
Recreational Chlorpromazine
Zambian Chlorpromazine
Chlorpromazine
COVID-19
COVID-19 Drug Treatment
Diagnosis
Drug treatment
Epidemiology
Hiccup
Humans
Male
Persistent hiccup
Post-acute COVID-19
Post-Acute COVID-19 Syndrome
SARS-CoV-2
Treatment Outcome

Semantics

Type Source Name
disease MESH hiccups
disease MESH COVID-19
drug DRUGBANK Chlorpromazine
disease VO report
disease MESH complications
disease MESH infections
disease MESH Severe Acute Respiratory Syndrome
disease IDO infection
disease MESH emergency
disease IDO history
disease MESH malignancy
drug DRUGBANK Ethanol
disease IDO blood
drug DRUGBANK Oxygen
drug DRUGBANK Medical air
disease VO dose
disease MESH Long Covid

Original Article

(Visited 3 times, 1 visits today)